![](https://www.canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBa2dFIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--f57e385f17747a3aeff46d8446e92887d805dbfe/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/Logos.png)
Relievant Medsystems
Relievant develops radiofrequency ablation of vertebral nerves for lower back pain.
Website
www.relievant.comPartner
Brent AhrensInvestment
Series B
Relievant develops radiofrequency ablation of vertebral nerves for lower back pain.
Series B